作为潜在的抗癌剂的新型蓝胺衍生物
Rania H Abd El-Hameed1, Omnia Aly2, Mariem E Mohamed1
1Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.
Molecules (Basel, Switzerland)
|April 26, 2025
概括
研究人员开发了针对Mcl-1和Bcl-2蛋白质的新型蓝胺衍生物,通过诱导细胞亡和细胞循环停止来对抗乳腺和卵巢癌.
科学领域:
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
- 药用化学 医学化学
背景情况:
- B细胞淋巴瘤2 (Bcl-2) 蛋白家族,特别是Mcl-1,是细胞亡和细胞循环进展的关键调节者.
- Mcl-1的失调与癌细胞的存活有关,这推动了针对乳腺和卵巢恶性瘤的向治疗的需求.
- 现有的治疗方法面临局限性,突出显示了对新型治疗策略的需求.
研究的目的:
- 合成具有对Mcl-1和Bcl-2的双重抑制活性的新型蓝胺衍生物.
- 评估这些化合物在诱导癌细胞中亡和细胞循环停止方面的潜力.
- 探索乳腺和卵巢癌的新治疗途径.
主要方法:
- 合成了一系列新的6替代的胺.
- 在SKOV-3 (卵巢) 和MCF-7 (乳腺) 癌细胞系上进行抗癌疗效测试.
- 细胞亡和细胞循环停止测试以确定作用机制.
主要成果:
- 合成的烯胺衍生物显示出显著的抗癌作用.
- 这些化合物对Mcl-1和Bcl-2具有双重抑制活性.
- 在测试的癌症细胞系中观察到成功诱导亡和细胞循环停止.
结论:
- 新型的烯胺衍生物显示出作为强效抗癌剂的前景.
- 这些化合物有效地向Mcl-1和Bcl-2,导致癌细胞死亡.
- 这些发现支持开发这些衍生品作为乳腺和卵巢癌的创新治疗方法.
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
134
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
134
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
181
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
181
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


